Shanghai, China

Sen Tao Song

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: The Innovations of Sen Tao Song

Introduction

Sen Tao Song is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive medications. His work focuses on improving treatment options for hypertension, a condition affecting millions worldwide.

Latest Patents

Sen Tao Song holds a patent for an antihypertensive pharmaceutical composition. This innovative composition includes levamlodipine or a pharmaceutically acceptable salt thereof, combined with indapamide. The combination is designed to treat hypertension effectively, achieving a synergistic antihypertensive effect. This invention also addresses the common side effects associated with the individual administration of these drugs, such as edema and glucose metabolism interference.

Career Highlights

Throughout his career, Sen Tao Song has worked with prominent companies in the pharmaceutical industry. He has been associated with Shihuida Pharmaceuticals Group (Jilin) Ltd. and Shihuida Pharmaceuticals Group Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Sen Tao Song has collaborated with several professionals in his field, including Yan Yang and Chuan Xiao Xue. These collaborations have likely enhanced his research and development efforts, leading to successful innovations in antihypertensive treatments.

Conclusion

Sen Tao Song's contributions to the pharmaceutical industry, particularly in antihypertensive medications, highlight his role as an influential inventor. His innovative approaches continue to impact the treatment of hypertension, showcasing the importance of research and collaboration in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…